Open Stage Seminar Oct. 12 (Fri.)  13:00 ~ 13:10

HEALIOS

Hardy Kagimoto

Chairman and CEO

HEALIOS’s approach to practical applications of regenerative medicine

Our Future with Regenerative Medicine Products.
Everyone wants to stay healthy. To develop more effective and safer drugs, in recent years, pharmaceutical development has been shifting toward the discovery of biodrugs.
The iPSC regenerative medicine products that HEALIOS is developing use cells which are the smallest unit of life, to develop biodrugs. We expect such biodrugs to serve as breakthrough drugs for chronic diseases caused by aging or hereditary conditions that result in cell degeneration.
HEALIOS believes such products will be part of a major paradigm shift in the life science arena that will lead the biorevolution of the 21st century.

Window Close